🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06979401
Starting soon Not applicable

Effect of Sensory Training on Functional Performance, Balance, Gait in Type 2 Diabetic Individuals With Neuropathy

NCT06979401 · tracked via the Priya Life Science Turkey tracker
Sponsor
Aylin DEMİR
Phase
Not applicable
Started
2025-06-15
Last updated
2025-05-19

Condition(s) studied

DiabetesType 2 DiabetesDiabetic Peripheral NeuropathyKinesiophobiaBalanceFunctional PerformanceGait AnalysisPlantar Sensation

Investigational drug(s) / intervention(s)

Exercise

Exercise: After obtaining informed consent to participate in the study, all participants will be evaluated by an experienced physiotherapist before group allocation. All participants will receive diabetic foot training. Then, the experimental group and the control group will be formed by a sequential random method. Foot sensory training will be applied to the experimental group and no intervention will be made to the control group. However, after the study is completed, sensory training will be provided to the participants in the control group who wish to do so. Foot sensory training will be performed by the researcher physiotherapist. Foot sensory training sessions will be planned for 6 weeks, 3 days a week. An initial assessment will be made before the sessions begin and a final assessment will be made after the 6-week foot sensory training program.

Study summary

Diabetic peripheral neuropathy (DPN) is a common complication of type 1 and type 2 diabetes. DPN is characterized by significant axonal degeneration and segmental demyelination affecting sensory and motor nerves. The effect of foot sole sensation on gait and balance parameters has been reported in various studies in the literature, however, no study has been found examining the effect of foot sensory training on plantar sensation, functional performance, balance, gait and kinesiophobia in type 2 diabetic individuals with neuropathy. In order to contribute to the literature, 40 type 2 diabetic individuals with neuropathy who applied to the Turgut Ozal Medical Center Endocrinology and Metabolic Diseases Polyclinic will be included in this randomized controlled study. After diabetic foot training is given to all participants, an experimental (20) and a control (20) group will be formed with a sequential random method. Foot sensory training will be given to the experimental group, while no intervention will be made to the control group, and sensory training will be given to the participants who wish after the study is completed. All participants will be evaluated for subscapular sense, functional performance, balance, walking and kinesiophobia at the beginning and end of the training. Subscapular sense will be evaluated with light touch, two-point discrimination and vibration tests. Functional performance evaluation will be made with timed up and go test and timed stair ascent-descend test. Kinesiophobia will be analyzed with Tampa Kinesiophobia Scale, Balance; One-Legged Stand Test and Y balance tests and walking will be analyzed with Kinect V2 camera based software. Physical activity levels will be evaluated with International Physical Activity Questionnaire-Short Form. The data taken into the research will be analyzed with SPSS (Statistical Program in Social Sciences) program. The values belonging to the data will be expressed with percentage, mean and standard deviation, and the significance level (p) will be taken as 0.05 for comparison tests.

Eligibility

Sex
ALL
Min age
35 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Being 35-65 years old * Being diagnosed with type 2 diabetes * Having achieved glycemic control * Having given less than 8 correct answers in the Semmes-Weinstein Monofilament test performed with a 5.07 monofilament * Getting a Neuropathy Disability Score of 3 and above * Being willing to participate in the study * Being literate Exclusion Criteria: * Having a neurological or orthopedic comorbidity * Having a respiratory disease such as uncontrolled COPD or asthma * Having active lower extremity ulceration * Using medications known to affect the postural control system such as benzodiazepines * Having nephropathy, retinopathy and diabetic arthritis at a level that may affect mobility in addition to neuropathy * Using a walking aid * Body Mass Index \>30 * Having communication problems * Not participating in at least 3 consecutive exercise sessions * Not participating in more than 30% of each session

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
İnonu University Malatya Battalgazi

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06979401 on ClinicalTrials.gov ↗ ← All trials in Turkey